default author photo

Jiazhen Cui

Zhejiang University - Bone Marrow Transplantation Center

Hangzhou

China

SCHOLARLY PAPERS

1

DOWNLOADS

45

TOTAL CITATIONS

2

Scholarly Papers (1)

1.

Factors Associated with Durable Progression-Free Survival in Relapsed or Refractory Multiple Myeloma Patients after Potent Anti-BCMA CAR-T Cell Therapy

Number of pages: 22 Posted: 01 Jun 2021
Zhejiang University - Bone Marrow Transplantation Center, Xi'an Jiaotong University (XJTU) - Department of Oncology, Zhejiang University - Bone Marrow Transplantation Center, Shanghai YaKe Biotechnology Ltd., Zhejiang University - Bone Marrow Transplantation Center, Zhejiang University - Bone Marrow Transplantation Center, Zhejiang University - Bone Marrow Transplantation Center, Zhejiang University - Bone Marrow Transplantation Center, Zhejiang University - Bone Marrow Transplantation Center, Zhejiang University - Bone Marrow Transplantation Center, Zhejiang University - Bone Marrow Transplantation Center, Shanghai YaKe Biotechnology Ltd., Shanghai YaKe Biotechnology Ltd., Shanghai YaKe Biotechnology Ltd., Zhejiang University - Bone Marrow Transplantation Center and Zhejiang University - Bone Marrow Transplantation Center
Downloads 45 (1,121,190)
Citation 2

Abstract:

Loading...

relapsed/refractory multiple myeloma; CAR-T cell; BCMA; prognosis-associated risk factors